Ginsenoside panaxatriol reverses TNBC paclitaxel resistance by inhibiting the IRAK1/NF-κB and ERK pathways
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ginsenoside panaxatriol reverses TNBC paclitaxel resistance by inhibiting the IRAK1/NF-κB and ERK pathways
Authors
Keywords
-
Journal
PeerJ
Volume 8, Issue -, Pages e9281
Publisher
PeerJ
Online
2020-06-03
DOI
10.7717/peerj.9281
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody
- (2019) Suping Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BCL-2 family isoforms in apoptosis and cancer
- (2019) Chloe F. A. Warren et al. Cell Death & Disease
- The role of IRAK1 in breast cancer patients treated with neoadjuvant chemotherapy
- (2019) Muwen Yang et al. OncoTargets and Therapy
- 20(S)-ginsenoside Rg3 sensitizes human non-small cell lung cancer cells to icotinib through inhibition of autophagy
- (2019) Xiao-Ju Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Ginsenoside Rb1 ameliorates Staphylococcus aureus-induced Acute Lung Injury through attenuating NF-κB and MAPK activation
- (2019) Aftab Shaukat et al. MICROBIAL PATHOGENESIS
- Therapeutic Strategies Targeting Cancer Stem Cells and Their Microenvironment
- (2019) Hao-Ran Sun et al. Frontiers in Oncology
- Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking of NF-κB mediated epithelial–mesenchymal transition and stemness
- (2018) Jingjing Wang et al. CANCER LETTERS
- MCL-1 is a prognostic indicator and drug target in breast cancer
- (2018) Kirsteen J. Campbell et al. Cell Death & Disease
- A multiomics analysis of S100 protein family in breast cancer
- (2018) Patrizia Cancemi et al. Oncotarget
- Targeting BCL-2 regulated apoptosis in cancer
- (2018) Kirsteen J. Campbell et al. Open Biology
- Targeting Cancer Stemness in the Clinic: From Hype to Hope
- (2018) Caner Saygin et al. Cell Stem Cell
- Understanding the Effectiveness of Natural Compound Mixtures in Cancer through Their Molecular Mode of Action
- (2017) Thazin Aung et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Molecular alterations in triple-negative breast cancer—the road to new treatment strategies
- (2017) Carsten Denkert et al. LANCET
- Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence
- (2017) Jian Yuan Goh et al. NATURE MEDICINE
- An autocrine inflammatory forward-feedback loop after chemotherapy withdrawal facilitates the repopulation of drug-resistant breast cancer cells
- (2017) Deyong Jia et al. Cell Death & Disease
- Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer
- (2017) Guilhem Bousquet et al. Oncotarget
- Nab-paclitaxel for the treatment of triple-negative breast cancer: Rationale, clinical data and future perspectives
- (2016) Francesco Schettini et al. CANCER TREATMENT REVIEWS
- Blocking the CCL2–CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model
- (2016) Kun-Yu Teng et al. MOLECULAR CANCER THERAPEUTICS
- Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand?
- (2016) S Baig et al. Cell Death & Disease
- Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer
- (2016) Tae-Hwe Heo et al. Oncotarget
- The Regulation of NF-κB Subunits by Phosphorylation
- (2016) Frank Christian et al. Cells
- Recent advances in ginseng as cancer therapeutics: a functional and mechanistic overview
- (2015) Alice S. T. Wong et al. NATURAL PRODUCT REPORTS
- IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
- (2015) Zhen Ning Wee et al. Nature Communications
- The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics
- (2015) A. N. Hata et al. Cancer Discovery
- The role of taxanes in triple-negative breast cancer: literature review
- (2015) Giorgio Mustacchi et al. Drug Design Development and Therapy
- Roles of the Bcl-2/Bax Ratio, Caspase-8 and 9 in Resistance of Breast Cancer Cells to Paclitaxel
- (2014) Simin Sharifi et al. Asian Pacific Journal of Cancer Prevention
- Targeting IRAK1 as a Therapeutic Approach for Myelodysplastic Syndrome
- (2013) Garrett W. Rhyasen et al. CANCER CELL
- Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8
- (2013) Z. C. Hartman et al. CANCER RESEARCH
- The complexity of NF-κB signaling in inflammation and cancer
- (2013) Bastian Hoesel et al. Molecular Cancer
- S100A7 enhances invasion of human breast cancer MDA-MB-468 cells through activation of nuclear factor-κB signaling
- (2013) Huamin Liu et al. World Journal of Surgical Oncology
- Enhanced oral bioavailability and anti-tumour effect of paclitaxel by 20(s)-ginsenoside Rg3in vivo
- (2012) Lei-Qiong Yang et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
- (2012) Swarnali Acharyya et al. CELL
- Ginsenosides as anticancer agents: In vitro and in vivo activities, structure–activity relationships, and molecular mechanisms of action
- (2012) Subhasree Ashok Nag Frontiers in Pharmacology
- Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation—The key step of inflammation
- (2011) Eun-Ha Joh et al. BIOCHEMICAL PHARMACOLOGY
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- NF-κB addiction and its role in cancer: ‘one size does not fit all’
- (2010) M M Chaturvedi et al. ONCOGENE
- S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis
- (2009) Julia Németh et al. HEPATOLOGY
- Dysregulation of apoptotic signaling in cancer: Molecular mechanisms and therapeutic opportunities
- (2008) Jessica Plati et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Is NF-κB a good target for cancer therapy? Hopes and pitfalls
- (2008) Véronique Baud et al. NATURE REVIEWS DRUG DISCOVERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More